Statistically Analysis of Carpal Tunnel Syndrome Diagnosis

October 14, 2022 updated by: İSMAİL CEYLAN

A Comprehensive Statistical Analysis for the Diagnosis of Carpal Tunnel Syndrome

Trap neuropathies; They are compression neuropathies that occur as a result of peripheral nerves being compressed for various reasons along their anatomical paths. Although each nerve has areas suitable for anatomical entrapment, compression can occur at any point along the nerve. Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy caused by compression of the median nerve at the wrist level. Its prevalence in the general population is 2.5-11%.

Although the majority of cases are idiopathic, it may also occur secondary to pathologies such as pregnancy, diabetes mellitus, thyroid dysfunction, arthritis, wrist fractures and acromegaly or occupation. The diagnosis of CTS is made clinically, but the best method for definitive diagnosis is electrophysiological examination.

Some anthropometric measurements that may be associated with CTS were made and their effect on the risk of CTS was investigated. In a study conducted by Sabry et al. in 2009, it was reported that there may be a relationship between BMI, wrist ratio (ratio of wrist depth to width) and wrist-palm ratio (ratio of wrist depth to palm length) and CTS risk. In a study by Lim et al. in 2008, it was reported that the critical value for wrist ratio was 0.70 and above. However, there were no studies reporting how many percent predictors of anthropometric measurements according to the severity of CTS.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The study was planned as a quantitative research. Socio-demographic information form, anthropometric measurements of hand grip strength, palm length, hand width length, wrist circumference length, Visual Analog Scale scale, EMG findings will be evaluated by hand dynamometer.

Trybus et al. Considering the study they conducted in patients with CTS in which they examined hand anthropometric measurements in CTS, it was planned to include 100 patients in the study with a power range of 80% and an effect width of 0.05.

Study Type

Observational

Enrollment (Anticipated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Merkez
      • Kırşehir, Merkez, Turkey, 40100
        • Recruiting
        • İsmail Ceylan
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Persons aged 18-65 years who apply to outpatient clinics with symptoms of CTS

Description

Inclusion Criteria:

  • Admitted to outpatient clinics with symptoms of CTS
  • Findings of CTS in physical examination
  • CTS diagnosis was confirmed by nerve conduction study
  • KTS grade mild or moderate
  • He has not received physical therapy for this reason in the previous 1 year
  • No steroid injection and no treatment for neuropathic pain (pregabalin, gabapentin, etc.)

Exclusion Criteria:

  • - Those under the age of 18 Those with a history of previous surgery or fracture of the affected hand and wrist Those with diabetes mellitus, chronic kidney failure, gout, rheumatoid arthritis, thyroid diseases
  • Pregnant Those with polyneuropathy, radiculopathy, plexopathy, thoracic outlet syndrome

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
carpal tunnel syndrome
  • Admitted to outpatient clinics with symptoms of CTS
  • Findings of CTS in physical examination
  • CTS diagnosis was confirmed by nerve conduction study
  • KTS grade mild or moderate
  • He has not received physical therapy for this reason in the previous 1 year
  • No steroid injection and no treatment for neuropathic pain (pregabalin, gabapentin, etc.)
The study was planned as a quantitative research. Socio-demographic information form, anthropometric measurements of hand grip strength, palm length, hand width length, wrist circumference length, Visual Analog Scale scale, EMG findings will be evaluated by hand dynamometer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand Grip Strength
Time Frame: 0-1 days
The grip strength of the dominant hand is measured using a standard adjustable digital grip dynamometer (Baseline Digital Smedley Hand Dynamometer). Handgrip strength is measured as follows: (a) Each subject is tested while sitting comfortably in a chair without armrests, with their back against the chair; (b) Each subject is instructed to sit with hips and knees flexed 90°, shoulders adducted and neutrally rotated, elbows flexed 90°, forearm rotation 0°, wrists dorsiflexed 0° to 30°, and ulnar deviation 0° to 15°; and asked to squeeze the dynamometer.
0-1 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand length
Time Frame: 0-1 days

Hand length is moderate when forearm and hand are brought to supination on a table.

is the distance from the tip of the finger to the midline of the distal wrist crease.

0-1 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2023

Primary Completion (Anticipated)

January 1, 2023

Study Completion (Anticipated)

February 1, 2023

Study Registration Dates

First Submitted

October 14, 2022

First Submitted That Met QC Criteria

October 14, 2022

First Posted (Actual)

October 18, 2022

Study Record Updates

Last Update Posted (Actual)

October 18, 2022

Last Update Submitted That Met QC Criteria

October 14, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe